Cargando…

Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment

BACKGROUND: Human papillomavirus (HPV) vaccines prevent HPV infection and cervical precancers. The impact of vaccinating women with a current infection or after treatment for an HPV-associated lesion is not fully understood. OBJECTIVES: To determine whether HPV-16/18 vaccination influences the outco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hildesheim, Allan, Gonzalez, Paula, Kreimer, Aimee R., Wacholder, Sholom, Schussler, John, Rodriguez, Ana C., Porras, Carolina, Schiffman, Mark, Sidawy, Mary, Schiller, John T., Lowy, Douglas R., Herrero, Rolando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967374/ https://www.ncbi.nlm.nih.gov/pubmed/26892991 http://dx.doi.org/10.1016/j.ajog.2016.02.021

Ejemplares similares

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
por: Kreimer, Aimée R., et al.
Publicado: (2011)

Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica
por: Herrero, Rolando, et al.
Publicado: (2013)

Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial
por: Panagiotou, Orestis A, et al.
Publicado: (2015)

Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials
por: Wacholder, Sholom, et al.
Publicado: (2010)

HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial
por: Tsang, Sabrina H., et al.
Publicado: (2022)

Comparison of Antibody Responses to Human Papillomavirus Vaccination as Measured by Three Assays
por: Robbins, Hilary A., et al.
Publicado: (2014)

Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies
por: Kreimer, Aimée R., et al.
Publicado: (2018)

Determinants of seropositivity among HPV-16/18 DNA positive young women
por: Porras, Carolina, et al.
Publicado: (2010)

A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection
por: Clarke, Megan A, et al.
Publicado: (2012)

HPV16 Seropositivity and Subsequent HPV16 Infection Risk in a Naturally Infected Population: Comparison of Serological Assays
por: Lin, Shih-Wen, et al.
Publicado: (2013)

A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica
por: Clarke, Megan, et al.
Publicado: (2013)

Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus
por: Robbins, Hilary A, et al.
Publicado: (2014)

Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer
por: Wang, Sophia S., et al.
Publicado: (2010)

Sequence Imputation of HPV16 Genomes for Genetic Association Studies
por: Smith, Benjamin, et al.
Publicado: (2011)

Single Nucleotide Polymorphisms in the PRDX3 and RPS19 and Risk of HPV Persistence and Cervical Precancer/Cancer
por: Safaeian, Mahboobeh, et al.
Publicado: (2012)

Analysis of cervical HPV infections among unvaccinated young adult women to inform vaccine strategies in this age group: the Costa Rica HPV Vaccine Trial
por: Sierra, Mónica S., et al.
Publicado: (2023)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection
por: Beachler, Daniel C., et al.
Publicado: (2016)

Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial
por: Baisley, Kathy, et al.
Publicado: (2022)

Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study
por: Castle, Philip E, et al.
Publicado: (2009)

Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes
por: Wagner, Sarah, et al.
Publicado: (2019)

Maturation of the Human Papillomavirus 16 Capsid
por: Cardone, Giovanni, et al.
Publicado: (2014)

Involvement of nucleophosmin (NPM1/B23) in assembly of infectious HPV16 capsids
por: Day, Patricia M., et al.
Publicado: (2015)

Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10 000 women in Costa Rica
por: Wang, S S, et al.
Publicado: (2003)

Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection
por: Cullen, Michael, et al.
Publicado: (2015)

Explanations for the high potency of HPV prophylactic vaccines
por: Schiller, John, et al.
Publicado: (2018)

Evolution and Taxonomic Classification of Alphapapillomavirus 7 Complete Genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70
por: Chen, Zigui, et al.
Publicado: (2013)

Assessment of Human Papillomavirus in Lung Tumor Tissue
por: Koshiol, Jill, et al.
Publicado: (2011)

A population-based cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria
por: Clarke, Megan A, et al.
Publicado: (2011)

Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica
por: Wang, S S, et al.
Publicado: (2004)

HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica
por: Hildesheim, A, et al.
Publicado: (2001)

Cervicovaginal microbiome and natural history of HPV in a longitudinal study
por: Usyk, Mykhaylo, et al.
Publicado: (2020)

Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors
por: Damm, Oliver, et al.
Publicado: (2009)

Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium
por: Robbins, Hilary A., et al.
Publicado: (2022)

Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women
por: Ramanakumar, Agnihotram V, et al.
Publicado: (2010)

Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada
por: Kohli, Michele, et al.
Publicado: (2012)

Variants of human papillomaviruses 16 (HPV16) in Uigur women in Xinjiang, China
por: He, Hongchang, et al.
Publicado: (2016)

Evaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening
por: BIAN, MEI-LU, et al.
Publicado: (2013)

Can human papillomavirus (HPV) genotyping classify non-16/18 high-risk HPV infection by risk stratification?
por: Sung, Yeoun Eun, et al.
Publicado: (2016)

Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18
por: Bogaards, Johannes A, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r18tb4audjg9q09hs19shchov1